GH1 and Alzheimer disease: Although GWI shares key pathological features with AD—including chronic neuroinflammation, metabolic dysfunction, and dysregulation of the GHRH-GH-IGF axis—our findings suggest that the mechanisms underlying the neuroprotective effects differ.